
PwC's Next in Health
Co -hosted by Glenn Hunzinger, US Health Industries leader, and Jennifer Colapietro, Consulting Commercial Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it’s policy, AI, innovation, care delivery, business model reinvention or bold moves for the future. If it’s happening in health industries, we’re talking about it.
PwC's Next in Health
Health Industries: U.S. Deals Outlook for 2025 and Beyond
Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include:
Key topics include:
- A look back at M&A activity in health industries in 2024
- The challenges and potential impediments that could affect deal volumes in the coming year
- How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions
- Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors
Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC
Linked materials:
- https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
- https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.